Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
2024 · The Lancet · 106 citations
https://doi.org/10.1016/s0140-6736(24)00921-8
D
Diana Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
1.5K
Citations
17
h-index
19
i10-index
Diana Kim is an academic researcher from University of British Columbia. The author has contributed to research in topics: Acute Ischemic Stroke Management & Vestibular and auditory disorders & Cerebrovascular and Carotid Artery Diseases. The author has an h-index of 17, co-authored 55 publications.
ORCID: 0000-0002-0243-799XPapers by this author
worksVenous Endothelial Marker COUP-TFII Regulates the Distinct Pathologic Potentials of Adult Arteries and Veins
2015 · Scientific Reports · 59 citations
https://doi.org/10.1038/srep16193
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase
2024 · Stroke · 8 citations
https://doi.org/10.1161/strokeaha.123.045320
Thrombolysis With Tenecteplase for Minor Disabling Stroke
2025 · JAMA Neurology · 2 citations
https://doi.org/10.1001/jamaneurol.2025.4152
Outcomes After Pericardiectomy in Constrictive Pericarditis After Heart Transplantation: A Case Series
2025 · The Journal of Heart and Lung Transplantation · 0 citations
https://doi.org/10.1016/j.healun.2025.02.1317
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat